XML 70 R40.htm IDEA: XBRL DOCUMENT v3.22.4
Goodwill and Intangible Assets (Tables)
12 Months Ended
Dec. 31, 2022
Goodwill and Intangible Assets Disclosure [Abstract]  
Summaries of Goodwill and Acquisitions-Related Intangibles Balances

Summaries of goodwill and intangible assets balances as of December 31, 2022 and 2021 were as follows:

 

 

 

December 31,

 

 

Weighted-Average Amortization Period

2022

 

 

2021

 

 

 

(in thousands)

 

Goodwill

 

$

143,027

 

 

$

50,897

 

 

 

 

 

 

 

 

In-process research & development

n/a

$

64,590

 

 

$

 

 

 

 

 

 

 

 

Royalty-free technology

10 Years

 

5,364

 

 

 

5,803

 

Less: accumulated amortization

 

 

(894

)

 

 

(387

)

Royalty-free technology, net

 

 

4,470

 

 

 

5,416

 

 

 

 

 

 

 

 

Customer relationships

13 Years

 

82,750

 

 

 

28,845

 

Less: accumulated amortization

 

 

(6,215

)

 

 

(1,125

)

Customer relationships, net

 

 

76,535

 

 

 

27,720

 

 

 

 

 

 

 

 

Trade name

8 Years

 

3,790

 

 

 

1,090

 

Less: accumulated amortization

 

 

(412

)

 

 

(45

)

Trade name, net

 

 

3,378

 

 

 

1,045

 

 

 

 

 

 

 

 

In-place lease intangible assets

5 Years

 

360

 

 

 

 

Less: accumulated amortization

 

 

(46

)

 

 

 

In-place lease intangible assets, net

 

 

314

 

 

 

 

 

 

 

 

 

 

 

Laboratory information system platform

5 Years

 

1,860

 

 

 

1,860

 

Less: accumulated amortization

 

 

(527

)

 

 

(155

)

Laboratory information system platform, net

 

 

1,333

 

 

 

1,705

 

 

 

 

 

 

 

 

Purchased patent

10 Years

 

29

 

 

 

31

 

Less: accumulated amortization

 

 

(6

)

 

 

(3

)

Purchased patent, net

 

 

23

 

 

 

28

 

Total intangible assets, net

 

$

150,643

 

 

$

35,914

 

Summary of Carrying Amount of Goodwill

Changes in the carrying amount of goodwill for the year ended December 31, 2022 and 2021 are as follows:

 

 

2022

 

 

2021

 

 

(in thousands)

 

Balance as of January 1,

 

 

 

 

 

Goodwill

$

50,897

 

 

$

 

Accumulated impairment losses

 

 

 

 

 

 

 

50,897

 

 

 

 

Goodwill acquired during year

 

 

 

 

 

Inform Diagnostics

 

71,845

 

 

 

 

Fulgent Pharma

 

22,055

 

 

 

 

CSI

 

 

 

 

27,484

 

FF Gene Biotech

 

 

 

 

23,082

 

 

 

93,900

 

 

 

50,566

 

 

 

 

 

 

 

Net exchange differences

 

 

 

 

 

FF Gene Biotech

 

(1,770

)

 

 

331

 

 

 

 

 

 

 

Balance as of December 31,

 

 

 

 

 

Goodwill

 

143,027

 

 

 

50,897

 

Accumulated impairment losses

 

 

 

 

 

 

$

143,027

 

 

$

50,897

 

Summary of Annual Amortization Expense For Acquisition-Related Intangibles

Based on the carrying value of intangible assets recorded as of December 31, 2022, and assuming no subsequent impairment of the underlying assets, the annual amortization expense for intangible assets is expected to be as follows:

 

 

Amounts

 

 

(in thousands)

 

2023

$

7,864

 

2024

 

7,864

 

2025

 

7,864

 

2026

 

7,554

 

2027

 

7,225

 

Thereafter

 

47,682

 

Total

$

86,053